CoChat

Change in Drusen Volume as a Novel Clinical Trial Endpoint for the Study of Complement Inhibition in Age-related Macular Degeneration

Open access
de Amorim Garcia Filho, Carlos Alexandre, Yehoshua, Zohar, Gregori, Giovanni, Nunes, Renata Portella, Penha, Fernando M., Moshfeghi, Andrew A., Zhang, Kang, Feuer, William, Rosenfeld, Philip J. · 2014 · Ophthalmic Surgery, Lasers and Imaging Retina
Cited by 79

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

BACKGROUND AND OBJECTIVE: To evaluate the change in drusen volume following treatment with eculizumab, a systemic inhibitor of complement component 5. PATIENTS AND METHODS: Single-center, prospective, randomized, double-masked clinical trial. Patients were randomized 2:1 to receive intravenous eculizumab or placebo over 26 weeks. Main outcome measure: decrease in drusen volume of at least 50% at 26-week follow-up. RESULTS: Mean drusen cube root volumes were 0.49 mm and 0.47 mm ( P = .64) at baseline and 0.51 mm and 0.42 mm ( P = .17) at 26 weeks in the eculizumab and placebo groups, respectively. In the placebo group, one eye had a decrease in drusen volume of at least 50% and two eyes developed neovascularization through 26 weeks. CONCLUSION: Systemic complement inhibition with eculizumab did not significantly reduce drusen volume. Drusen growth was dependent on the number of complement at-risk alleles. Future trials should consider the use of a composite clinical trial endpoint in which efficacy is defined by the treatment’s ability to prevent drusen growth, neovascularization, and the formation of geographic atrophy over 1 year. [ Ophthalmic Surg Lasers Imaging Retina . 2014;45:18–31.]

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3928/23258160-20131217-01

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 79

Metadata

Authors
de Amorim Garcia Filho, C. A., Yehoshua, Z., Gregori, G., Nunes, R. P., Penha, F. M., Moshfeghi, A. A., Zhang, K., Feuer, W., & Rosenfeld, P. J.
Venue
Ophthalmic Surgery, Lasers and Imaging Retina
Publisher
SLACK, Inc.
Published
2014-01
Volume
45
Issue
1
Pages
18-31
ISSN
  • 1542-8877 (ISSN-L)
  • 2325-8160
  • 2325-8179
OpenAlex
W2318395464
Cited by
79
References
12
FWCI
7.53
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Change in Drusen Volume as a Novel Clinical Trial Endpoint for the Study of Complement Inhibition in Age-related Macular Degeneration. https://app.cochat.ai/papers/10.3928/23258160-20131217-01
The paper
de Amorim Garcia Filho, C. A., Yehoshua, Z., Gregori, G., Nunes, R. P., Penha, F. M., Moshfeghi, A. A., Zhang, K., Feuer, W., & Rosenfeld, P. J. (2014). Change in Drusen Volume as a Novel Clinical Trial Endpoint for the Study of Complement Inhibition in Age-related Macular Degeneration. Ophthalmic Surgery, Lasers and Imaging Retina. https://doi.org/10.3928/23258160-20131217-01

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.